Key Highlights
- Q3 net revenue reached an all-time high of $206.7M, representing 11% year-over-year growth and exceeding the $201.35M consensus estimate
- Company posted adjusted EPS of $0.02, dramatically outperforming the anticipated -$0.14 loss
- Cannabis segment revenue expanded 19% to $64.8M, fueled by a remarkable 73% increase in international cannabis sales
- Adjusted EBITDA climbed 19% to $10.7M; fiscal 2026 EBITDA outlook maintained at $62M–$72M
- Company completed BrewDog acquisition for approximately £40M and revealed strategic Carlsberg collaboration beginning in 2027
Tilray Brands delivered unprecedented quarterly performance in its fiscal 2026 third quarter, achieving net revenue of $206.7 million. This represents an 11% increase compared to the $185.8 million recorded in the prior-year period and surpassed analyst projections.
The real story was the profitability shock. Wall Street had projected a 14-cent per share loss. Instead, Tilray delivered adjusted earnings of $0.02 per share. This dramatic outperformance triggered an 8.01% surge in TLRY shares.
The company reported a net loss of $25.2 million for the quarter, which represents a dramatic turnaround from the $793.5 million loss recorded in the comparable quarter last year.
Gross profit reached $55.0 million, marking a 6% year-over-year increase, while the consolidated gross margin stood at 27%.
The cannabis division delivered particularly impressive results. Overall cannabis revenue jumped 19% to $64.8 million. International cannabis net revenue exploded by 73%, while cannabis flower sales volume doubled compared to the previous year.
In Canada, adult-use and medical cannabis net revenue increased 8%, solidifying Tilray’s position as the leading cannabis revenue generator in the country.
The distribution business also performed exceptionally well. It generated a Q3 record of $83.0 million in net revenue, with distribution gross profit rising to $10.0 million and margin expansion to 12%.
Tilray completed its Project 420 synergy initiative during the quarter. This program achieved approximately $33 million in annualized cost reductions.
Strategic BrewDog Acquisition and Carlsberg Alliance
Following the quarter’s conclusion, Tilray finalized its purchase of BrewDog, the prominent UK craft beer company, for roughly £40 million in cash. CEO Irwin Simon characterized the transaction as a strategic move to establish a “scaled global beverage platform.”
Additionally, Tilray unveiled a collaborative agreement with Carlsberg, scheduled to launch in 2027. According to the company, this partnership significantly extends its market presence throughout Europe, the Middle East, Australia, Asia-Pacific, and the United States.
Adjusted EBITDA for the third quarter totaled $10.7 million, representing a 19% improvement from the $9.0 million reported in the same quarter last year.
Full-Year Outlook Maintained
Executive leadership maintained its fiscal 2026 adjusted EBITDA guidance of $62 million to $72 million. This projection indicates anticipated growth between 13% and 31% relative to fiscal year 2025.
Analyst sentiment on TLRY currently stands at Hold, reflecting one Buy recommendation and five Hold ratings issued over the last three months. The consensus price target is $8.97, suggesting potential upside of approximately 38.64% from current trading levels.
Notwithstanding the strong Q3 performance, TLRY shares remain down 28.35% year-to-date and have declined 0.68% over the trailing twelve-month period.
